These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 39220153)
21. Clinical Features in Children With Kawasaki Disease Shock Syndrome: A Systematic Review and Meta-Analysis. Zheng Z; Huang Y; Wang Z; Tang J; Chen X; Li Y; Li M; Zang C; Wang Y; Wang L; Ma Y; Sun L Front Cardiovasc Med; 2021; 8():736352. PubMed ID: 34621802 [No Abstract] [Full Text] [Related]
22. Comparison of Clinical Features and Inflammatory Markers between Kawasaki Disease Shock Syndrome and Kawasaki Disease without Shock: A Meta-Analysis. Zhang H; Zheng Q; Li F J Healthc Eng; 2021; 2021():1486089. PubMed ID: 34966519 [TBL] [Abstract][Full Text] [Related]
23. Biomarkers of intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease. Kong WX; Ma FY; Fu SL; Wang W; Xie CH; Zhang YY; Gong FQ World J Pediatr; 2019 Apr; 15(2):168-175. PubMed ID: 30809758 [TBL] [Abstract][Full Text] [Related]
24. Clinical aspects for differential diagnosis of Kawasaki disease shock syndrome: a case control study. Park WY; Lee SY; Kim GB; Song MK; Kwon HW; Bae EJ; Choi EH; Park JD BMC Pediatr; 2021 Jan; 21(1):25. PubMed ID: 33413220 [TBL] [Abstract][Full Text] [Related]
25. [Predictive value of serum ferritin and a new predictive model for intravenous immunoglobulin resistance in Kawasaki disease]. Zhang YJ; Bai HT; Chen PL Zhonghua Er Ke Za Zhi; 2021 Dec; 59(12):1080-1085. PubMed ID: 34856668 [No Abstract] [Full Text] [Related]
26. Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease. Shao S; Zhou K; Liu X; Liu L; Wu M; Deng Y; Duan H; Li Y; Hua Y; Wang C J Clin Endocrinol Metab; 2021 Sep; 106(10):e4210-e4220. PubMed ID: 33837779 [TBL] [Abstract][Full Text] [Related]
27. [Combined predictive value of the risk factors influencing the short-term prognosis of sepsis]. Chen R; Zhou X; Rui Q; Wang X Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Mar; 32(3):307-312. PubMed ID: 32385994 [TBL] [Abstract][Full Text] [Related]
28. Clinical manifestations associated with Kawasaki disease shock syndrome in Mexican children. Gámez-González LB; Murata C; Muñoz-Ramírez M; Yamazaki-Nakashimada M Eur J Pediatr; 2013 Mar; 172(3):337-42. PubMed ID: 23152158 [TBL] [Abstract][Full Text] [Related]
29. Correlation between Coagulation Fibrinolysis Function and Outcomes during Hospitalization in Patients with Severe Traumatic Hemorrhagic Shock. Zhang L; Lin M; Tang X; Tang Y Emerg Med Int; 2022; 2022():3775868. PubMed ID: 35811611 [TBL] [Abstract][Full Text] [Related]
30. Extracorporeal Membrane Oxygenation Support for Cardiac Dysfunction Due to Kawasaki Disease Shock Syndrome. Zhang H; Xie L; Xiao T Front Pediatr; 2019; 7():221. PubMed ID: 31245335 [No Abstract] [Full Text] [Related]
31. Kawasaki disease with shock as the primary manifestation: How to distinguish from toxic shock syndrome?: A case report and literature review. Wang W; Wang H; Wang H; Cheng J Medicine (Baltimore); 2024 Aug; 103(31):e39199. PubMed ID: 39093792 [TBL] [Abstract][Full Text] [Related]
32. Kawasaki Disease Shock Syndrome in Japan and Comparison With Multisystem Inflammatory Syndrome in Children in European countries. Suzuki J; Abe K; Matsui T; Honda T; Yasukawa K; Takanashi JI; Hamada H Front Pediatr; 2021; 9():625456. PubMed ID: 33816399 [TBL] [Abstract][Full Text] [Related]
33. [Predictive value of von Willebrand factor for venous thromboembolism in critically ill patients based on propensity score matching]. Yue J; Wan L; Wang G; Zhang R; Zhang X; Liu O; Yu X; Huang Q; Ren Z Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Jan; 36(1):73-77. PubMed ID: 38404276 [TBL] [Abstract][Full Text] [Related]
34. Clinical Value of Coagulation Function Indicators in Children with Severe Pneumonia. Song J; Li N; Li R; Xu Y Int J Gen Med; 2024; 17():4659-4668. PubMed ID: 39429960 [TBL] [Abstract][Full Text] [Related]
35. Predictive value of albumin for intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients. Zhang R; Shuai S; Zhang H; Cai J; Cui N; Tang M; Xing S; Gao Y; Liu X; Yang X Ital J Pediatr; 2023 Jun; 49(1):78. PubMed ID: 37357258 [TBL] [Abstract][Full Text] [Related]
36. Similarities and Differences between Multisystem Inflammatory Syndrome in Children (MIS-C) and Kawasaki Disease Shock Syndrome. Lee J; Kim BJ; Cho KS; Rhim JW; Lee SY; Jeong DC Children (Basel); 2023 Sep; 10(9):. PubMed ID: 37761488 [TBL] [Abstract][Full Text] [Related]
37. Comparison of COVID-19-associated multisystem inflammatory syndrome in children (MIS-C) and Kawasaki disease shock syndrome: case reports and literature review. Lee S; Kim D; Kim BJ; Rhim JW; Lee SY; Jeong DC J Rheum Dis; 2023 Oct; 30(4):272-277. PubMed ID: 37736588 [TBL] [Abstract][Full Text] [Related]
38. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better? Li W; He X; Zhang L; Wang Z; Wang Y; Lin H; Yuan J; Xie X; Qin Y; Huang P Cardiovasc Ther; 2021; 2021():6660407. PubMed ID: 34239607 [TBL] [Abstract][Full Text] [Related]
39. Acute Appendicitis as the Initial Presentation of Kawasaki Disease Shock Syndrome in Children. Chang YH; Lin CY; Liu LH; Huang FH; Cheng YJ Children (Basel); 2022 Nov; 9(12):. PubMed ID: 36553263 [TBL] [Abstract][Full Text] [Related]
40. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease. Xie T; Wang Y; Fu S; Wang W; Xie C; Zhang Y; Gong F Pediatr Rheumatol Online J; 2017 Mar; 15(1):17. PubMed ID: 28320400 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]